compound, pharmaceutical composition, methods for selectively binding to the estrogen receptor beta in a patient, treating a patient afflicted with a beta estrogen receptor mediated disease condition, treating prostate cancer and benign prostatic hyperplasia in a patient, and , use of a compound

摘要

"COMPOUND, PHARMACEUTICAL COMPOSITION, METHODS FOR SELECTIVELY CONNECTING THE ESTROGEN BETA RECEIVER IN A PATIENT, TO TREAT A PATIENT ACHIEVED OF A MEDIATED ENERGY BETA RECIPIENT, FOR PROSTATE BETAPIAN PROSTATEE AND USE OF A COMPOUND ". This invention relates to novel heterocycles that are melanin-concentrating hormone receptor 1 (MCHR1) antagonists, also referred to as 11CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicine. Compounds of the invention have the formula: (I)